MannKind will get 35% of the profits while Sanofi is set to get 65% of profits on Afrezza. Afrezza was approved with a black box warning which states, "Acute bronchospasm has been observed in patients with asthma and COPD using Afrezza. Afrezza is contraindicated in patients with chronic lung disease such as asthma …
Read More »Short Bursts of Fast Walking Provide Better Glucose Control
A study found short bursts of fast walking resulted in better blood glucose control than did walking at a steady pace. Data on participants aged 57 to 61 revealed that only the interval walkers achieved a reduction in glucose levels at four months, while the control group and those who …
Read More »Weight loss Linked to Green-plant Membranes
Women who ate 5 grams daily of green-plant membranes purified from spinach lost more weight and had fewer urges to eat unhealthy foods than did those given a placebo, Swedish researchers reported. Women who consumed green-plant membranes also had higher secretions of the satiety hormone GLP-1. Green-plant membranes slow fat …
Read More »Desserts Made with Sucralose and Dextrin Do Not Raise After-meal BG Levels
Researchers found that desserts made with added soluble fiber (dextrin) and sucralose in place of added sugar, had positive effects on blood sugar and insulin levels in people with type 2 diabetes. Consumption of desserts made with sucralose and soluble fiber did not raise after-meal levels of glucose, insulin or …
Read More »Hydrogen Sulfide Has Potential Diabetes and CVD Health Benefits
It may have a reputation for being highly toxic, but when used in the right tiny dosage, hydrogen sulfide may offer potential health benefits for a range of issues, from diabetes to stroke, heart attacks and dementia. A new compound (AP39), could hold the key to future therapies, by targeting …
Read More »Life Expectancy Decreases as BMI Surpasses 40
Obese adults are more likely to die from all causes than those within normal weight range, but particularly from heart disease, cancer and diabetes. The meta-analysis of 20 prospective cohort studies found life expectancy decreased as BMI surpassed 40. "Our results suggest that otherwise healthy, non-smoking adults with BMI values …
Read More »Lifestyle, Metformin, Delay Diabetes
New data from the ongoing US Diabetes Prevention Program (DPP) show that randomizing overweight or obese people at high risk for type 2 diabetes to intensive lifestyle change or giving them the oral agent metformin can reduce or delay the development of the disease for as long as 15 years. …
Read More »Lorcaserin Improved Glucose Control Regardless of Weight Loss
A study of 509 type 2 diabetes patients found that lorcaserin was more effective than diet and exercise alone in reducing A1C levels regardless of whether the patients lost weight. The patients, randomly assigned to either lorcaserin or placebo along with diet and exercise, had A1c levels between 7% and …
Read More »ADA: Walkable Neighborhoods Cut Diabetes Rates
Residents of areas that encourage walking also have lower obesity rates. Those are the finding from two studies that showed those living in an area that encourages walking are also three times more likely to walk or bike and half as likely to drive to get from one place to …
Read More »Out-of-pocket Costs for Type 2 Diabetes Patients Have Risen with Wider Uptake of Insulin Analogs
Researchers found that in 2000, patients paid median out-of-pocket costs of $19 per prescription, but that his jumped to $36 in 2010. During that time, use of human synthetic insulin dropped off (from 96% to 15%) while use of short- and long-acting analogs such as glargine, detemir, and aspart increased …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.